Publicaciones (432) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. A comprehensive study of the academic benefits and practical recommendations to include resistance training programs in institutional education

    Frontiers in Psychology, Vol. 15

  2. Abnormal Histopathological Expression of Klotho, Ferroptosis, and Circadian Clock Regulators in Pancreatic Ductal Adenocarcinoma: Prognostic Implications and Correlation Analyses

    Biomolecules, Vol. 14, Núm. 8

  3. Abordaje terapéutico nutricional del paciente con desnutrición relacionada con la enfermedad

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 15, pp. 882-895

  4. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  5. Angiosarcoma cardiaco, un caso clínico

    Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 9, Núm. 1, pp. 26-28

  6. Areas of interest and sentiment analysis towards second generation antipsychotics, lithium and mood stabilizing anticonvulsants: Unsupervised analysis using Twitter

    Journal of Affective Disorders, Vol. 351, pp. 649-660

  7. Autophagy in Its (Proper) Context: Molecular Basis, Biological Relevance, Pharmacological Modulation, and Lifestyle Medicine

    International Journal of Biological Sciences, Vol. 20, Núm. 7, pp. 2532-2554

  8. Awareness and Self-Reported Knowledge and Training on Nutrition in Older People among Primary Care Practitioners

    Journal of Frailty and Aging, Vol. 13, Núm. 2, pp. 157-162

  9. Beaver tail liver

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 8, pp. 873-875

  10. C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Archivos de Bronconeumologia, Vol. 60, Núm. 6, pp. 344-349

  11. COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant

    Cancers, Vol. 16, Núm. 2

  12. Ceftaroline fosamil treatment patterns and outcomes in adults with community-acquired pneumonia: a real-world multinational, retrospective study

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 3

  13. Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure

    Digestive and Liver Disease, Vol. 56, Núm. 10, pp. 1721-1729

  14. Clinical nutrition in primary care: ESPEN position paper

    Clinical Nutrition

  15. Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease: An international bi-institutional study

    Journal of Gastroenterology and Hepatology (Australia), Vol. 39, Núm. 1, pp. 149-156

  16. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis

    Gut, Vol. 73, Núm. 7, pp. 1183-1198

  17. Comprehensive evaluation of genetic and acquired thrombophilia markers for an individualized prediction of clinical thrombosis in patients with lymphoma and multiple myeloma

    Journal of Thrombosis and Thrombolysis, Vol. 57, Núm. 6, pp. 984-995

  18. Connecting epigenetics and inflammation in vascular senescence: state of the art, biomarkers and senotherapeutics

    Frontiers in Genetics, Vol. 15

  19. Corrigendum to: “Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D” [Biomed. Pharmacother. 150 (2022) 1−11] (Biomedicine & Pharmacotherapy (2022) 150, (S0753332222003547), (10.1016/j.biopha.2022.112965))

    Biomedicine and Pharmacotherapy

  20. Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3

    Histology and histopathology, Vol. 39, Núm. 1, pp. 35-40